Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2004 3
2005 8
2006 4
2007 3
2008 6
2009 3
2010 3
2011 2
2012 5
2013 3
2016 6
2017 3
2018 2
2019 7
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells.
Kaltschmidt C, Banz-Jansen C, Benhidjeb T, Beshay M, Förster C, Greiner J, Hamelmann E, Jorch N, Mertzlufft F, Pfitzenmaier J, Simon M, Schulte Am Esch J, Vordemvenne T, Wähnert D, Weissinger F, Wilkens L, Kaltschmidt B. Kaltschmidt C, et al. Among authors: Wilkens L. Cancers (Basel). 2019 May 11;11(5):655. doi: 10.3390/cancers11050655. Cancers (Basel). 2019. PMID: 31083587 Free PMC article. Review.
RSPO2 gene rearrangement: a powerful driver of β-catenin activation in liver tumours.
Longerich T, Endris V, Neumann O, Rempel E, Kirchner M, Abadi Z, Uhrig S, Kriegsmann M, Weiss KH, Breuhahn K, Mehrabi A, Weber TF, Wilkens L, Straub BK, Rosenwald A, Schulze F, Brors B, Froehling S, Pellegrino R, Budczies J, Schirmacher P, Stenzinger A. Longerich T, et al. Among authors: Wilkens L. Gut. 2019 Jul;68(7):1287-1296. doi: 10.1136/gutjnl-2018-317632. Epub 2019 Feb 2. Gut. 2019. PMID: 30901310
A standardized suprapubic bottom-to-up approach in robotic right colectomy: technical and oncological advances for complete mesocolic excision (CME).
Schulte Am Esch J, Iosivan SI, Steinfurth F, Mahdi A, Förster C, Wilkens L, Nasser A, Sarikaya H, Benhidjeb T, Krüger M. Schulte Am Esch J, et al. Among authors: Wilkens L. BMC Surg. 2019 Jul 1;19(1):72. doi: 10.1186/s12893-019-0544-2. BMC Surg. 2019. PMID: 31262302 Free PMC article.
Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma.
Bui KC, Barat S, Chen X, Bozko P, Scholta T, Nguyen MLT, Bhuria V, Xing J, Nguyen LT, Le HS, Velavan TP, Sipos B, Wilkens L, Malek NP, Plentz RR. Bui KC, et al. Among authors: Wilkens L. Exp Cell Res. 2018 Mar 1;364(1):59-67. doi: 10.1016/j.yexcr.2018.01.028. Epub 2018 Jan 31. Exp Cell Res. 2018. PMID: 29366806
Targeting c-MET by LY2801653 for treatment of cholangiocarcinoma.
Barat S, Bozko P, Chen X, Scholta T, Hanert F, Götze J, Malek NP, Wilkens L, Plentz RR. Barat S, et al. Among authors: Wilkens L. Mol Carcinog. 2016 Dec;55(12):2037-2050. doi: 10.1002/mc.22449. Epub 2016 Jan 12. Mol Carcinog. 2016. PMID: 26757360
Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 2 Expression in Brain Arteriovenous Malformations and its Association with Brain Arteriovenous Malformation Size.
Neyazi B, Tanrikulu L, Wilkens L, Hartmann C, Stein KP, Dumitru CA, Sandalcioglu IE. Neyazi B, et al. Among authors: Wilkens L. World Neurosurg. 2017 Jun;102:79-84. doi: 10.1016/j.wneu.2017.02.116. Epub 2017 Mar 6. World Neurosurg. 2017. PMID: 28279775
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.
Schiffgens S, Wilkens L, Brandes AA, Meier T, Franceschi E, Ermani M, Hartmann C, Sandalcioglu IE, Dumitru CA. Schiffgens S, et al. Among authors: Wilkens L. Oncotarget. 2016 Aug 23;7(34):55169-55180. doi: 10.18632/oncotarget.10465. Oncotarget. 2016. PMID: 27409829 Free PMC article.
59 results
Jump to page